Acacia Recalls 217K IV Devices Over Faulty Component

Law360, New York (February 10, 2010, 2:17 PM EST) -- Acacia Inc. has recalled 217,000 infusion therapy IV systems because of a defect in a component manufactured by Becton Dickinson & Co. that can cause air embolism, blood leakage and even death.

Brea, Calif.-based Acacia announced the voluntary recall for its IV Extension Sets with BD Q-Syte Luer Access Device after BD notified the company that it had received complaints relating to the Q-Syte component of the device.

“Patient safety and the quality and safety of our products are Acacia’s first priorities,” Acacia said in the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.